{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-036380","form_type":"8-K","ticker":"PAVM","cik":"0001624326","company_name":"PAVmed Inc.","filed_at":"2024-09-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.848238+00:00","generated_at":"2026-05-31T04:37:00.475880+00:00","sec_items":["2.01","5.02","3.01","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"PAVmed deconsolidates Lucid Diagnostics, expects ~$70M gain; faces Nasdaq delisting, appoints new director","bullets":["Deconsolidated Lucid from financials; expects ~$70M non-cash gain in Q3 2024.","Pro forma stockholders' equity improves $9.7M but still deficit of ~$9.0M.","Received Nasdaq delisting notice for failing min market value; will appeal with hearing in Oct.","Dr. Cox and Harvey resigned from board; Dr. Agrawal appointed as Class B director.","PAVmed retains 31.3M Lucid shares (no change); deconsolidation does not affect ownership."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-036380","json":"https://secwatch.observer/filing/0001493152-24-036380.json","markdown":"https://secwatch.observer/filing/0001493152-24-036380.md","text":"https://secwatch.observer/filing/0001493152-24-036380.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1624326/000149315224036380/0001493152-24-036380-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1624326/000149315224036380/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T04:37:00.475880+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"01e0c998b3","claim":"James L. Cox, M.D. resigned as Director at PAVmed Inc..","evidence_excerpt":"James L. Cox, M.D., and Joan B. Harvey resigned from the Company’s board of directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1624326/000149315224036380/0001493152-24-036380-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"41a1bdcd11","claim":"Sundeep Agrawal, M.D. was appointed as Class B Director at PAVmed Inc..","evidence_excerpt":"the Company’s board of directors appointed Sundeep Agrawal, M.D. as a Class B director.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1624326/000149315224036380/0001493152-24-036380-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class B Director"}],"fact_type":"executive_change"},{"claim_id":"f464be6231","claim":"Joan B. Harvey resigned as Director at PAVmed Inc..","evidence_excerpt":"James L. Cox, M.D., and Joan B. Harvey resigned from the Company’s board of directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1624326/000149315224036380/0001493152-24-036380-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}